Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom

Recombinant viral vector systems expressing exogenous feline paramyxovirus genes and vaccines made therefrom

US Patent 11033616 · Granted Jun 15, 2021

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2025
Modified Marek's disease virus, and vaccines made therefrom2025
Single domain antibodies binding to tetanus neurotoxin2024
Immunogenic compositions and vaccines comprising African swine fever virus pepti2024
Paramyxoviridae expression system2023
Immunogenic compositions and vaccines comprising African swine fever virus pepti2023
Modified Marek's disease virus, and vaccines made therefrom2022
Modified PEDV spike protein2022
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2022
Recombinant vectors expressing antigens of avian influenza virus and uses thereo2021
Intranasal vector vaccine against porcine epidemic diarrhea2021
Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses2020